Your browser is no longer supported. Please, upgrade your browser.
Settings
RGEN Repligen Corporation daily Stock Chart
RGEN [NASD]
Repligen Corporation
Index- P/E84.54 EPS (ttm)0.26 Insider Own0.30% Shs Outstand32.94M Perf Week-0.32%
Market Cap724.02M Forward P/E48.84 EPS next Y0.45 Insider Trans0.00% Shs Float32.45M Perf Month-5.50%
Income8.70M PEG- EPS next Q0.07 Inst Own94.70% Short Float6.17% Perf Quarter-17.68%
Sales78.50M P/S9.22 EPS this Y-50.00% Inst Trans-0.40% Short Ratio6.38 Perf Half Y-39.47%
Book/sh3.69 P/B5.96 EPS next Y32.35% ROA6.40% Target Price35.00 Perf Year-8.57%
Cash/sh2.09 P/C10.51 EPS next 5Y- ROE7.40% 52W Range20.07 - 42.48 Perf YTD-22.30%
Dividend- P/FCF82.28 EPS past 5Y31.40% ROI6.80% 52W High-48.26% Beta1.54
Dividend %- Quick Ratio5.10 Sales past 5Y24.80% Gross Margin57.70% 52W Low9.52% ATR1.60
Employees136 Current Ratio6.10 Sales Q/Q29.40% Oper. Margin15.90% RSI (14)42.67 Volatility7.10% 7.57%
OptionableYes Debt/Eq0.00 EPS Q/Q100.00% Profit Margin11.00% Rel Volume1.21 Prev Close21.35
ShortableYes LT Debt/Eq0.00 EarningsMar 11 BMO Payout0.00% Avg Volume314.02K Price21.98
Recom1.70 SMA20-2.35% SMA50-15.14% SMA200-32.70% Volume378,300 Change2.95%
Nov-06-15Downgrade Jefferies Buy → Hold
Apr-23-15Reiterated Jefferies Buy $25 → $38
Mar-07-11Downgrade Rodman & Renshaw Mkt Outperform → Mkt Perform
Jun-30-09Initiated Merriman Buy
Jun-12-08Reiterated Rodman & Renshaw Mkt Outperform $11 → $9
Sep-10-07Reiterated Rodman & Renshaw Mkt Outperform $6 → $8
Apr-12-07Reiterated Rodman & Renshaw Mkt Outperform $5 → $6
Jan-20-16 04:59PM  8 Stocks Moving In Wednesday's After-Hours Session +12.38%
Dec-30-15 04:41PM  Why These Four Stocks Are Moving In Wednesday's After-Hours Session
Dec-29-15 09:03AM  Why You Shouldn't Bet Against Repligen (RGEN) Stock
Dec-21-15 09:26AM  Repligen Corp. breached its 50 day moving average in a Bullish Manner : December 21, 2015
Dec-16-15 10:04AM  Repligen Corp. Value Analysis (NASDAQ:RGEN) : December 16, 2015
Dec-15-15 01:01PM  Repligen Corp. Earnings Analysis: Q3, 2015 By the Numbers
Dec-14-15 02:53PM  Here are the 20 top-performing stocks in Mass. for 2015 at bizjournals.com
Dec-09-15 09:20AM  Repligen Corp. breached its 50 day moving average in a Bullish Manner : December 9, 2015 -5.61%
Dec-08-15 01:17PM  REPLIGEN CORP Financials
Dec-04-15 09:55AM  What Biogens sudden cash spike could say about potential acquisitions at bizjournals.com
Nov-24-15 09:11AM  Here Is What Hedge Funds Think About Repligen Corporation (RGEN) at Insider Monkey
Nov-11-15 07:30AM  Repligen to Present at the Stifel 2015 Healthcare Conference GlobeNewswire
Nov-09-15 09:55AM  Repligen Corp. breached its 50 day moving average in a Bearish Manner : November 9, 2015
Nov-06-15 01:49PM  Why Repligen Corporation Shares Are Falling at Motley Fool -17.20%
Nov-05-15 04:13PM  Edited Transcript of RGEN earnings conference call or presentation 5-Nov-15 1:30pm GMT -6.98%
08:25AM  Repligen tops 3Q revenue forecasts
07:55AM  REPLIGEN CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
07:30AM  Repligen Reports Third Quarter 2015 Financial Results GlobeNewswire
07:07AM  Q3 2015 Repligen Corp Earnings Release - Before Market Open
Oct-22-15 06:20PM  CORRECTION -- Repligen to Report Third Quarter 2015 Financial Results GlobeNewswire
07:30AM  Repligen to Report Third Quarter 2015 Financial Results GlobeNewswire
Oct-19-15 09:30AM  Repligen, DeVry Education, International Business Machines, Fiserv and Apple highlighted as Zacks Bull and Bear of the Day
09:01AM  Bull of the Day: Repligen (RGEN)
Sep-28-15 02:15PM  ETFs with exposure to Repligen Corp. : September 28, 2015 -6.64%
10:32AM  Repligen Corp. breached its 50 day moving average in a Bearish Manner : September 28, 2015
Sep-24-15 08:10AM  Wednesday's After-Hours Movers: 10 Stocks To Watch
Sep-17-15 01:34PM  ETFs with exposure to Repligen Corp. : September 17, 2015
10:22AM  Repligen Corp. breached its 50 day moving average in a Bearish Manner : September 17, 2015
Sep-16-15 09:30AM  The Zacks Analyst Blog Highlights: VIVUS, Regeneron Pharmaceuticals, Gilead Sciences, Repligen and Affymetrix
Sep-15-15 11:36AM  Biotech Poised to Rebound: 5 Growth Picks
08:41AM  REPLIGEN CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
07:30AM  Repligen Appoints Glenn P. Muir to Board of Directors GlobeNewswire
Aug-25-15 08:55AM  Is Repligen (RGEN) an Incredible Growth Stock? 3 Reasons Why It Will Be Tough to Beat
Aug-08-15 08:10PM  10-Q for Repligen Corp. at Company Spotlight
Aug-06-15 12:49PM  Edited Transcript of RGEN earnings conference call or presentation 6-Aug-15 12:30pm GMT
10:07AM  Repligen posts 2Q profit
07:51AM  REPLIGEN CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
07:30AM  Repligen Reports Second Quarter 2015 Financial Results GlobeNewswire
07:07AM  Q2 2015 Repligen Corp Earnings Release - Before Market Open
Aug-04-15 11:45AM  After 240% Gain, Is Repligen Stock Still a Buy? at Motley Fool
Jul-29-15 07:30AM  Repligen to Report Second Quarter 2015 Financial Results GlobeNewswire
Jul-21-15 02:15PM  Its earnings season: Here are 9 local biotech firms that are actually making a profit at bizjournals.com -6.54%
Jun-30-15 03:15PM  Market sends a message: Cash is king at MarketWatch
Jun-29-15 06:33PM  IBD Market Wrap - 06/29/15
Jun-26-15 05:07AM  Edited Transcript of RGEN presentation 3-Jun-15 12:00pm GMT
May-26-15 01:00PM  Repligen to Present at Jefferies 2015 Healthcare Conference GlobeNewswire
May-22-15 07:56AM  REPLIGEN CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
May-16-15 09:10AM  Very High-Profile Insider Selling Marks Roller-Coaster Market Week at 24/7 Wall St.
May-13-15 11:39AM  Why Danaher's Purchase of Pall Means More M&A is on the Way at Barrons.com
May-10-15 08:11PM  10-Q for Repligen Corp. at Company Spotlight
May-08-15 03:51PM  REPLIGEN CORP Files SEC form 10-Q, Quarterly Report
May-07-15 10:58AM  Repligen posts 1Q profit +17.42%
08:47AM  Repligen Reports First Quarter 2015 Financial Results at noodls
07:47AM  REPLIGEN CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
07:30AM  Repligen Reports First Quarter 2015 Financial Results GlobeNewswire
07:07AM  Q1 2015 Repligen Corp Earnings Release - Before Market Open
May-03-15 08:13PM  10-K for Repligen Corp. at Company Spotlight
May-01-15 02:35PM  Biotech execs remember MIT professor: He inspired so many scientists at bizjournals.com +6.71%
Apr-29-15 08:01AM  Repligen to Report First Quarter 2015 Financial Results at noodls
07:30AM  Repligen to Report First Quarter 2015 Financial Results GlobeNewswire
Mar-20-15 08:21AM  Repligen (RGEN) Enters Overbought Territory - Tale of the Tape
Mar-17-15 05:24PM  REPLIGEN CORP Files SEC form 10-K, Annual Report
Mar-13-15 07:27AM  Repligen reports 4Q loss +16.74%
07:22AM  REPLIGEN CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
07:21AM  Repligen Reports Financial Results for the Year 2014 and Issues 2015 Financial Guidance at noodls
07:07AM  Q4 2014 Repligen Corp Earnings Release - Before Market Open
07:00AM  Repligen Reports Financial Results for the Year 2014 and Issues 2015 Financial Guidance GlobeNewswire
Mar-09-15 03:44PM  Repligen to Report Year 2014 Financial Results and Provide 2015 Financial Guidance at noodls
03:09PM  Repligen to Report Year 2014 Financial Results and Provide 2015 Financial Guidance GlobeNewswire
Mar-02-15 07:47AM  REPLIGEN CORP Files SEC form 8-K/A, Change in Directors or Principal Officers, Financial Statements and Exhibits
Feb-10-15 07:30AM  Repligen Completes Expansion of U.S. Facility GlobeNewswire
Feb-04-15 07:30AM  Repligen to Present at 2015 Leerink Global Healthcare Conference GlobeNewswire
Jan-30-15 07:31AM  REPLIGEN CORP Files SEC form 8-K, Termination of a Material Definitive Agreement
Jan-26-15 09:31AM  Repligen (RGEN) Shares March Higher, Can It Continue? - Tale of the Tape
Jan-23-15 04:31PM  REPLIGEN CORP Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Stat
Jan-21-15 07:07AM  Repligen Corporation Names Tony Hunt as Next Chief Executive Officer at noodls
07:00AM  Repligen Corporation Names Tony Hunt as Next Chief Executive Officer GlobeNewswire
Jan-09-15 11:47AM  Here are the best-performing stocks so far in 2015 at MarketWatch
Jan-08-15 07:42AM  REPLIGEN CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online +23.09%
07:30AM  Repligen Receives Milestone Payment From Pfizer GlobeNewswire
Nov-12-14 07:30AM  Repligen to Present at Stifel Healthcare Conference 2014 GlobeNewswire
Nov-10-14 07:08PM  10-Q for Repligen Corp. Company Spotlight
Nov-07-14 11:37AM  REPLIGEN CORP Files SEC form 10-Q, Quarterly Report EDGAR Online
Nov-06-14 10:15AM  Repligen posts 3Q profit AP -5.08%
07:59AM  REPLIGEN CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
07:30AM  Repligen Reports Third Quarter 2014 Financial Results GlobeNewswire
07:07AM  Q3 2014 Repligen Corp Earnings Release - Before Market Open CCBN
Nov-05-14 01:17PM  Repligen to Present at Stephens Inc. Fall Investment Conference GlobeNewswire
Oct-23-14 07:30AM  Repligen to Report Third Quarter 2014 Financial Results GlobeNewswire
Oct-10-14 11:23AM  Repligen to Host Investor & Analyst Event on October 16 GlobeNewswire
Sep-26-14 01:04PM  Nike Jumps On Strong Results; Powell Industries Shares Slide Benzinga
Aug-18-14 11:07AM  REPLIGEN CORP Files SEC form 8-K/A, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhi EDGAR Online +6.73%
Aug-11-14 07:28AM  REPLIGEN CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
07:07AM  Q2 2014 Repligen Corporation Earnings Release - Before Market Open CCBN
07:00AM  Repligen Reports Second Quarter 2014 Financial Results GlobeNewswire
Jul-28-14 07:30AM  Repligen to Report Second Quarter 2014 Financial Results GlobeNewswire
Jul-15-14 03:17PM  CFO Moves: Repligen Corp., Top Image Systems Ltd. at The Wall Street Journal
07:51AM  REPLIGEN CORP Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Stat EDGAR Online
07:30AM  Repligen Hires Jon K. Snodgres as Chief Financial Officer GlobeNewswire
Jul-02-14 01:48PM  3 Stocks to Get on Your Watchlist at Motley Fool
Repligen Corporation, a life sciences company, develops, manufactures, and markets consumable bioprocessing products for use in the production of monoclonal antibodies and other biologic drugs. The company manufactures various forms of Protein A, a critical reagent used in biomanufacturing to separate and purify monoclonal antibodies. It also supplies various growth factor and cell filtration products, which are used to increase cell growth and productivity during the fermentation step of biomanufacturing, and chromatography products for purification of biologic products. In addition, the company manufactures and sells chromatography products, including OPUS pre-packed columns for biologics purification, as well as proprietary Protein A media and quality control test kits. Further, it has a portfolio of therapeutic product candidates, which include histone deacetylase inhibitor for the treatment of Friedreich's ataxia disease; and RG1068, a synthetic human hormone developed as a novel imaging agent for the detection of pancreatic duct abnormalities in combination with magnetic resonance imaging in patients with pancreatitis and other pancreatic diseases. Additionally, Repligen Corporation offers alternating tangential flow system, a filtration device used to improve product yield during the fermentation step of the biologic drug manufacturing process. The company sells its bioprocessing products directly and through distributors to various life sciences companies, biopharmaceutical manufacturing companies, and contract manufacturing organizations worldwide. Repligen Corporation was founded in 1981 and is headquartered in Waltham, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Benjamin HowardVP Business DevelopmentNov 19Option Exercise3.335,00016,65016,554Nov 20 02:55 PM
Benjamin HowardVP Business DevelopmentJun 09Sale37.487,697288,48611,554Jun 10 03:36 PM
Benjamin HowardVP Business DevelopmentJun 08Sale38.3227,3031,046,36819,251Jun 10 03:36 PM
RUSCHE JAMES RSenior Vice PresidentMay 15Sale41.3215,000619,83396,849May 19 08:05 AM
HERLIHY WALTER CPRESIDENT, CEOMay 12Sale38.9745,4311,770,332262,430May 14 12:45 PM
HERLIHY WALTER CPRESIDENT, CEOMay 11Sale38.6835,7151,381,610317,861May 12 01:25 PM
HERLIHY WALTER CPRESIDENT, CEOMay 08Sale37.5568,8542,585,468353,576May 12 01:25 PM
RYAN THOMAS F JRDirectorMay 08Sale37.1920,000743,80020,312May 12 08:38 AM
HERLIHY WALTER CPRESIDENT AND CEOMar 23Sale31.7623,686752,173422,430Mar 23 06:32 PM
HERLIHY WALTER CPRESIDENT AND CEOMar 20Sale32.5185027,629446,116Mar 23 06:32 PM
HERLIHY WALTER CPRESIDENT AND CEOMar 19Sale33.0849,6951,643,762446,966Mar 20 04:50 PM
RYAN THOMAS F JRDirectorMar 19Sale32.6210,000326,18740,312Mar 20 04:50 PM
RUSCHE JAMES RSenior Vice PresidentMar 19Sale33.3014,650487,845111,849Mar 25 08:05 PM
Benjamin HowardVP Business DevelopmentMar 18Option Exercise8.9013,807122,86962,349Mar 19 05:41 PM
Benjamin HowardVP Business DevelopmentMar 18Sale32.6315,795515,44346,554Mar 19 05:41 PM